COVIVIO HOTELS SACA (COVH.PA) Fundamental Analysis & Valuation

EPA:COVH • FR0000060303

Current stock price

23.9 EUR
+0.1 (+0.42%)
Last:

This COVH.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. COVH.PA Profitability Analysis

1.1 Basic Checks

  • In the past year COVH was profitable.
  • In the past year COVH had a positive cash flow from operations.
  • Of the past 5 years COVH 4 years were profitable.
  • COVH had a positive operating cash flow in 4 of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • COVH has a Return On Assets of 2.89%. This is comparable to the rest of the industry: COVH outperforms 59.52% of its industry peers.
  • Looking at the Return On Equity, with a value of 5.88%, COVH is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.68%, COVH is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 78.96%, COVH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • COVH's Profit Margin has declined in the last couple of years.
  • COVH has a Operating Margin of 101.55%. This is amongst the best in the industry. COVH outperforms 100.00% of its industry peers.
  • COVH's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y0.45%
OM growth 5Y15.26%
PM growth 3Y-12.76%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. COVH.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COVH is destroying value.
  • COVH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.04, we must say that COVH is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.04, COVH is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
  • COVH has a debt to FCF ratio of 12.71. This is a negative value and a sign of low solvency as COVH would need 12.71 years to pay back of all of its debts.
  • COVH has a Debt to FCF ratio (12.71) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
  • The Debt to Equity ratio of COVH (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.04
ROIC/WACC0.69
WACC5.37%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
  • COVH's Current ratio of 1.16 is amongst the best of the industry. COVH outperforms 80.95% of its industry peers.
  • A Quick Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
  • COVH's Quick ratio of 1.16 is amongst the best of the industry. COVH outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. COVH.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.96% over the past year.
  • Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.51% on average per year.
  • The Revenue for COVH has decreased by -15.46% in the past year. This is quite bad
  • Measured over the past years, COVH shows a quite strong growth in Revenue. The Revenue has been growing by 8.97% on average per year.
EPS 1Y (TTM)25.96%
EPS 3Y-15.51%
EPS 5YN/A
EPS Q2Q%86.66%
Revenue 1Y (TTM)-15.46%
Revenue growth 3Y-1.04%
Revenue growth 5Y8.97%
Sales Q2Q%-17.84%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. COVH.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.51, COVH is valued correctly.
  • The rest of the industry has a similar Price/Earnings ratio as COVH.
  • When comparing the Price/Earnings ratio of COVH to the average of the S&P500 Index (26.21), we can say COVH is valued rather cheaply.
  • COVH is valuated correctly with a Price/Forward Earnings ratio of 13.86.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH indicates a slightly more expensive valuation: COVH is more expensive than 66.67% of the companies listed in the same industry.
  • COVH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.51
Fwd PE 13.86
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • COVH's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of COVH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.32
EV/EBITDA 17.23
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. COVH.PA Dividend Analysis

5.1 Amount

  • COVH has a Yearly Dividend Yield of 6.76%, which is a nice return.
  • Compared to an average industry Dividend Yield of 5.32, COVH pays a bit more dividend than its industry peers.
  • COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 6.76%

5.2 History

  • The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years5
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • COVH pays out 19.15% of its income as dividend. This is a sustainable payout ratio.
  • COVH's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP19.15%
EPS Next 2YN/A
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVH.PA Fundamentals: All Metrics, Ratios and Statistics

COVIVIO HOTELS SACA

EPA:COVH (4/8/2026, 11:56:45 AM)

23.9

+0.1 (+0.42%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)07-14
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.78B
Revenue(TTM)235.20M
Net Income(TTM)205.77M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.76%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.15%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.51
Fwd PE 13.86
P/S 14.49
P/FCF 16.32
P/OCF 10.32
P/B 1.08
P/tB 1.19
EV/EBITDA 17.23
EPS(TTM)1.91
EY7.99%
EPS(NY)1.72
Fwd EY7.21%
FCF(TTM)1.46
FCFY6.13%
OCF(TTM)2.32
OCFY9.69%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.85
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.45%
OM growth 5Y15.26%
PM growth 3Y-12.76%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.95
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.12
Cash Conversion 103.44%
Profit Quality 112.46%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.04
F-Score6
WACC5.37%
ROIC/WACC0.69
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.96%
EPS 3Y-15.51%
EPS 5YN/A
EPS Q2Q%86.66%
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.46%
Revenue growth 3Y-1.04%
Revenue growth 5Y8.97%
Sales Q2Q%-17.84%
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y-0.59%
EBIT growth 5Y25.59%
EBIT Next Year-5.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.31%
OCF growth 3YN/A
OCF growth 5YN/A

COVIVIO HOTELS SACA / COVH.PA Fundamental Analysis FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status for COVH stock?

ChartMill assigns a valuation rating of 3 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


Can you provide the profitability details for COVIVIO HOTELS SACA?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 4 / 10.


What is the valuation of COVIVIO HOTELS SACA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 12.51 and the Price/Book (PB) ratio is 1.08.


Can you provide the dividend sustainability for COVH stock?

The dividend rating of COVIVIO HOTELS SACA (COVH.PA) is 6 / 10 and the dividend payout ratio is 19.15%.